Michelo Simuyandi

996 total citations
61 papers, 540 citations indexed

About

Michelo Simuyandi is a scholar working on Infectious Diseases, Endocrinology and Nutrition and Dietetics. According to data from OpenAlex, Michelo Simuyandi has authored 61 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 19 papers in Endocrinology and 17 papers in Nutrition and Dietetics. Recurrent topics in Michelo Simuyandi's work include Viral gastroenteritis research and epidemiology (29 papers), Child Nutrition and Water Access (15 papers) and Hepatitis Viruses Studies and Epidemiology (12 papers). Michelo Simuyandi is often cited by papers focused on Viral gastroenteritis research and epidemiology (29 papers), Child Nutrition and Water Access (15 papers) and Hepatitis Viruses Studies and Epidemiology (12 papers). Michelo Simuyandi collaborates with scholars based in Zambia, Ghana and United States. Michelo Simuyandi's co-authors include Roma Chilengi, Samuel Bosomprah, Caroline Cleopatra Chisenga, Obvious Nchimunya Chilyabanyama, Paul Kelly, Sylvia Becker‐Dreps, John Mwaba, Sallie R. Permar, Baoming Jiang and Lauren B. Beach and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Michelo Simuyandi

56 papers receiving 523 citations

Peers

Countries citing papers authored by Michelo Simuyandi

Since Specialization

Citations

This map shows the geographic impact of Michelo Simuyandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelo Simuyandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelo Simuyandi more than expected).

Fields of papers citing papers by Michelo Simuyandi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelo Simuyandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelo Simuyandi. The network helps show where Michelo Simuyandi may publish in the future.

Co-authorship network of co-authors of Michelo Simuyandi

This figure shows the co-authorship network connecting the top 25 collaborators of Michelo Simuyandi. A scholar is included among the top collaborators of Michelo Simuyandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelo Simuyandi. Michelo Simuyandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Application of a Novel Proteomic Microarray Reveals High Exposure to Diarrhoeagenic Escherichia coli among Children in Zambia Participating in a Phase I Clinical Trial 2024 ·Microorganisms ·(unknown), (unknown), Obvious Nchimunya Chilyabanyama, (unknown), Caroline Cleopatra Chisenga, (unknown), Arlo Randall, Xiaowu Liang, Tobias George Barnard, Michelo Simuyandi, Roma Chilengi	0
2	Human cytomegalovirus seropositivity and its influence on oral rotavirus vaccine immunogenicity: a specific concern for HIV-exposed-uninfected infants 2024 ·Clinical & Experimental Immunology ·(unknown), Samuel Bosomprah, Roma Chilengi, Michelo Simuyandi, Caroline Cleopatra Chisenga, (unknown), (unknown), Martin R. Goodier	1
3	Seroconversion and Kinetics of Vibriocidal Antibodies during the First 90 Days of Re-Vaccination with Oral Cholera Vaccine in an Endemic Population 2024 ·Vaccines ·Caroline Cleopatra Chisenga, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michelo Simuyandi, Adam F. Cunningham, David A. Sack, Samuel Bosomprah	2
4	Comparative analysis of cholera serum vibriocidal antibodies from Convalescent and vaccinated adults in Zambia 2024 ·Vaccine ·(unknown), Samuel Bosomprah, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michelo Simuyandi, (unknown), Fred Kapaya, Adam F. Cunningham, Roma Chilengi, David A. Sack, Caroline Cleopatra Chisenga	1
5	Safety, tolerability, and immunogenicity of an oral inactivated ETEC vaccine (ETVAX®) with dmLT adjuvant in healthy adults and children in Zambia: An age descending randomised, placebo-controlled trial 2023 ·Vaccine ·(unknown), (unknown), (unknown), Obvious Nchimunya Chilyabanyama, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Samuel Bosomprah, Nils Carlin, Joanna Kaim, (unknown), Michelo Simuyandi, Roma Chilengi, Ann‐Mari Svennerholm	10
6	Assessment of the influence of ABO blood groups on oral cholera vaccine immunogenicity in a cholera endemic area in Zambia 2023 ·BMC Public Health ·Caroline Cleopatra Chisenga, Samuel Bosomprah, Obvious Nchimunya Chilyabanyama, Peter Alabi, Michelo Simuyandi, John Mwaba, (unknown), (unknown), (unknown), Roma Chilengi	5
7	Prevalence of Diarrhoeagenic Escherichia coli among Children Aged between 0–36 Months in Peri-Urban Areas of Lusaka 2023 ·Microorganisms ·(unknown), Samuel Bosomprah, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Paul Somwe, Obvious Nchimunya Chilyabanyama, Caroline Cleopatra Chisenga, Monde Muyoyeta, Michelo Simuyandi, Tobias George Barnard, Roma Chilengi	4
8	Drivers of informal sector and non-prescription medication use in pediatric populations in a low- and middle-income setting: A prospective cohort study in Zambia 2023 ·SHILAP Revista de lepidopterología ·(unknown), Logan Stuck, (unknown), Michelo Simuyandi, Caroline Cleopatra Chisenga, Constance Schultsz, Vanessa Harris	3
9	Epstein–Barr Virus Detection in the Central Nervous System of HIV-Infected Patients 2022 ·Pathogens ·(unknown), Omar K. Siddiqi, Obvious Nchimunya Chilyabanyama, Matthew Bates, Caroline Cleopatra Chisenga, Michelo Simuyandi, Edford Sinkala, Xin Dang, Igor J. Koralnik, Roma Chilengi, Sody Munsaka	4
10	Immunogenicity and waning immunity from the oral cholera vaccine (Shanchol™) in adults residing in Lukanga Swamps of Zambia 2022 ·PLoS ONE ·(unknown), Michelo Simuyandi, John Mwaba, (unknown), Peter Alabi, Obvious Nchimunya Chilyabanyama, (unknown), (unknown), (unknown), Samuel Bosomprah, Roma Chilengi, Geoffrey Kwenda, Caroline Cleopatra Chisenga	10
11	Sickle Cell Disease in Early Infancy: A Case Report 2022 ·Pediatric Health Medicine and Therapeutics ·(unknown), (unknown), (unknown), (unknown), Michelo Simuyandi	1
12	Three transmission events of Vibrio cholerae O1 into Lusaka, Zambia 2021 ·BMC Infectious Diseases ·John Mwaba, Amanda K. Debes, (unknown), (unknown), Michelo Simuyandi, (unknown), (unknown), Caroline Cleopatra Chisenga, Shan Li, Mathieu Almeida, Jacquelyn S. Meisel, Aaron Shibemba, (unknown), Victor Mukonka, Geoffrey Kwenda, David A. Sack, Roma Chilengi, O. Colin Stine	11
13	Exploring willingness to participate in future Human Infection Studies in Lusaka, Zambia: A nested qualitative exploratory study 2021 ·PLoS ONE ·(unknown), (unknown), Chanda Mwamba, Jenala Chipungu, (unknown), (unknown), Michelo Simuyandi, Roma Chilengi, Anjali Sharma	0
14	Identification of cholera hotspots in Zambia: A spatiotemporal analysis of cholera data from 2008 to 2017 2020 ·PLoS neglected tropical diseases ·John Mwaba, Amanda K. Debes, (unknown), Victor Mukonka, (unknown), Caroline Cleopatra Chisenga, Michelo Simuyandi, Geoffrey Kwenda, David A. Sack, Roma Chilengi, Mohammad Ali	28
15	Evaluating the costs of cholera illness and cost-effectiveness of a single dose oral vaccination campaign in Lusaka, Zambia 2019 ·PLoS ONE ·(unknown), Michelo Simuyandi, (unknown), Anjali Sharma, Obvious Nchimunya Chilyabanyama, (unknown), Mazyanga L. Mazaba, Roma Chilengi	14
16	Early linear growth retardation: results of a prospective study of Zambian infants 2019 ·BMC Public Health ·Roma Chilengi, (unknown), (unknown), Obvious Nchimunya Chilyabanyama, (unknown), (unknown), Michelo Simuyandi, (unknown)	8
17	vAetiology of Diarrhoea in Children Under Five in Zambia Detected Using Luminex xTAG Gastrointestinal Pathogen Panel 2018 ·Caroline Cleopatra Chisenga, Samuel Bosomprah, (unknown), (unknown), John Mwaba, Michelo Simuyandi, Roma Chilengi	12
18	Norovirus infections in young children in Lusaka Province, Zambia: clinical characteristics and molecular epidemiology 2017 ·BMC Infectious Diseases ·Leigh M. Howard, (unknown), (unknown), Michelo Simuyandi, M. Brad Guffey, Jeffrey S. A. Stringer, H. Benjamin, Kathryn M. Edwards, Roma Chilengi	11
19	Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants 2016 ·PLoS ONE ·Roma Chilengi, Michelo Simuyandi, Lauren B. Beach, (unknown), Sylvia Becker‐Dreps, Devy Emperador, Daniel E. Velásquez, Samuel Bosomprah, Baoming Jiang	56
20	Improving Validity of Informed Consent for Biomedical Research in Zambia Using a Laboratory Exposure Intervention 2014 ·PLoS ONE ·Joseph Mumba Zulu, (unknown), Ellen Besa, Patrick Kaonga, Caroline Cleopatra Chisenga, (unknown), Michelo Simuyandi, (unknown), Paul Kelly	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact